A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Oh Young | - |
dc.contributor.author | Kang, Dae-Hwan | - |
dc.contributor.author | Lee, Dong Ho | - |
dc.contributor.author | Chung, Il-Kwun | - |
dc.contributor.author | Jang, Jae-Young | - |
dc.contributor.author | Kim, Jin-Il | - |
dc.contributor.author | Cho, Jin-Woong | - |
dc.contributor.author | Rew, Jong-Sun | - |
dc.contributor.author | Lee, Kang-Moon | - |
dc.contributor.author | Kim, Kyoung Oh | - |
dc.contributor.author | Choi, Myung-Gyu | - |
dc.contributor.author | Lee, Sang-Woo | - |
dc.contributor.author | Lee, Soo-Teik | - |
dc.contributor.author | Kim, Tae-Oh | - |
dc.contributor.author | Shin, Yong-Woon | - |
dc.contributor.author | Seol, Sang-Yong | - |
dc.date.accessioned | 2021-08-11T22:25:34Z | - |
dc.date.available | 2021-08-11T22:25:34Z | - |
dc.date.issued | 2014-10 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.issn | 1976-3786 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/11847 | - |
dc.description.abstract | Misoprostol is reported to prevent non-steroidal anti-inflammatory drug (NSAID)-associated gastroduodenal complications. There is, however, limited information regarding the efficacy of DA-9601 in this context. We performed a comparative study on the relative efficacy of DA-9601 and misoprostol for prevention of NSAID-associated complications. In this multicenter, double-blinded, active-controlled, stratified randomized, parallel group, non-inferiority trial, 520 patients who were to be treated with an NSAID (aceclofenac, 100 mg, twice daily) over a 4-week period were randomly assigned to groups for coincidental treatment with DA-9601 (60 mg, thrice daily) (236 patients for full analysis) or misoprostol (200 mu g, thrice daily) (242 patients for full analysis). A total of 236 patients received DA-9601 and 242 received misoprostol. The primary endpoint was the gastric protection rate, and secondary endpoints were the duodenal protection rate and ulcer incidence rate. Endpoints were assessed by endoscopy after the 4-week treatment period. Drug-related adverse effects, including gastrointestinal (GI) symptoms, were also compared. At week 4, the gastric protection rates with DA-9601 and misoprostol were 81.4 % (192/236) and 89.3 % (216/242), respectively. The difference between the groups was -14.2 %, indicating non-inferiority of DA-9601 to misoprostol. Adverse event rates were not different between the two groups; however, the total scores for GI symptoms before and after administration were significantly lower in the DA-9601 group than in the misoprostol group (-0.2 +/- A 2.8 vs 1.2 +/- A 3.2; p < 0.0001). DA-9601 is as effective as misoprostol in preventing NSAID-associated gastroduodenal complications, and has a superior adverse GI effect profile. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한약학회 | - |
dc.title | A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.1007/s12272-014-0408-3 | - |
dc.identifier.wosid | 000342441800009 | - |
dc.identifier.bibliographicCitation | Archives of Pharmacal Research, v.37, no.10, pp 1308 - 1316 | - |
dc.citation.title | Archives of Pharmacal Research | - |
dc.citation.volume | 37 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1308 | - |
dc.citation.endPage | 1316 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001921312 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | - |
dc.subject.keywordPlus | PEPTIC-ULCER DISEASE | - |
dc.subject.keywordPlus | HELICOBACTER-PYLORI INFECTION | - |
dc.subject.keywordPlus | GASTRIC EPITHELIAL-CELLS | - |
dc.subject.keywordPlus | PLACEBO-CONTROLLED TRIAL | - |
dc.subject.keywordPlus | LONG-TERM USERS | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | ARTEMISIA-ASIATICA | - |
dc.subject.keywordPlus | GASTROINTESTINAL COMPLICATIONS | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordAuthor | DA-9601(Stilen (R)) | - |
dc.subject.keywordAuthor | Misoprostol | - |
dc.subject.keywordAuthor | NSAID-associated | - |
dc.subject.keywordAuthor | Gastroduodenal injury | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.